ANROAlto Neuroscience Inc.
Slide 1 of 3
Company Overview
Name
Alto Neuroscience Inc.
52W High
$15.78
52W Low
$1.60
Market Cap
$482.8M
Dividend Yield
0%
Price/earnings
-0.52
P/E
-0.52
Tags
Dividends
No dividend
Sentiment
Score
Bullish
72
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 2 of 3
Income Statement
Total Revenue
Operating Revenue
Total Gross Profit
Total Operating Income
$-15M
Net Income
$-14.2M
EV to EBITDA
$0.00
EV to Revenue
$0.00
Price to Book value
$4.33
Price to Earnings
$0.00
Additional Data
Selling, General & Admin Expense
$4.4M
Research & Development Expense
$10.5M
Total Operating Expenses
$-15M
Interest Expense
$-650K
Interest & Investment Income
$1.5M
Other Income / (Expense), net
$-112K
Slide 3 of 3
Earnings History
Estimated EPS
Reported EPS
N/A Slide 1 of 5
Company Overview
Name
Alto Neuroscience Inc.
52W High
$15.78
52W Low
$1.60
Market Cap
$482.8M
Dividend Yield
0%
Price/earnings
-0.52
P/E
-0.52
Tags
Dividends
No dividend
Slide 2 of 5
Sentiment
Score
Bullish
72
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 3 of 5
Income Statement
Total Revenue
Operating Revenue
Total Gross Profit
Total Operating Income
$-15M
Net Income
$-14.2M
EV to EBITDA
$0.00
EV to Revenue
$0.00
Price to Book value
$4.33
Price to Earnings
$0.00
Slide 4 of 5
Additional Data
Selling, General & Admin Expense
$4.4M
Research & Development Expense
$10.5M
Total Operating Expenses
$-15M
Interest Expense
$-650K
Interest & Investment Income
$1.5M
Other Income / (Expense), net
$-112K
Slide 5 of 5
Earnings History
Estimated EPS
Reported EPS
N/AUpcoming Earnings
We were not able to find an announced earnings date for this symbol yet. Check back again later
Company Info
CEO
Amit Etkin
Location
California, USA
Exchange
NYSE
Website
https://www.altoneuroscience.com
Summary
We are a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging neurobiology to develop personalized and highly effective treatment options.
Company Info
CEO
Amit Etkin
Location
California, USA
Exchange
NYSE
Website
https://www.altoneuroscience.com
Summary
We are a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging neurobiology to develop personalized and highly effective treatment options.
